Fazio, N, Biffi, R, Maibach, R, Hayoz, S, Thierstein, S, Brauchli, P, Bernhard, J, Stupp, R, Andreoni, B, Renne, G, Crosta, C, Morant, R, Chiappa, A
, Luca, F, Zampino, MG, Huber, O, Goldhirsch, A, de Braud, F, Roth, AD, Pace, U, Cenciarelli, S, Pozzi, S, Bertani, E, Mura, S, Lorizzo, K, Di Meglio, G, Ravizza, D, Boselli, S, Matter, M, Richter, M, Monfardini, S, Dittrich, C, Häfner, M, Clemens, M & Crowe, S 2016, '
Preoperative versus postoperative docetaxel-cisplatin- fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial',
Annals of Oncology, vol. 27, no. 4, pp. 668-673.
https://doi.org/10.1093/annonc/mdv620